(Q37919156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

review article

1 reference

title

Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Johan C Brandt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

19 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

Photochemistry and Photobiology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1240-1296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848905%20AND%20SRC:MED&resulttype=core&format=json

New drugs and future developments in photodynamic therapy

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Structure and biodistribution relationships of photodynamic sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The history of photodetection and photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

How does photodynamic therapy work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mitotic inhibition by phenylporphines and tetrasulfonated aluminium phthalocyanine in combination with light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

pH-dependent spectral properties of HpIX, TPPS2a, mTHPP and mTHPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Time-resolved microspectrofluorometry and fluorescence lifetime imaging of photosensitizers using picosecond pulsed diode lasers in laser scanning microscopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

pH-dependent modification of lipophilicity of porphyrin-type photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in human plasma by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Determination of 5,10,15,20-tetra-(m-hydroxyphenyl)chlorin in tissues by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Importance of the ionization states of m-THPC for its HPLC fluorescence detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A direct sensitized fluorimetric determination of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin [m-THPC (Foscan)] in human plasma using a cyclodextrin inclusion complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Chemical analysis of cancer therapy photosensitizers by two-step laser mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Molecular fluorescence excitation-emission matrices relevant to tissue spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Dynamic capillaroscopy: a minimally invasive technique for assessing photodynamic effects in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Time-dependent photodynamic damage to blood vessels: correlation with serum photosensitizer levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

MALDI-TOF mass spectrometric analysis for the characterization of the 5,10,15,20-tetrakis- (m-hydroxyphenyl)bacteriochlorin (m-THPBC) photoproducts in biological environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Characterization by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry of the major photoproducts of temoporfin (m-THPC) and bacteriochlorin (m-THPBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Characterization of photoproducts of m-THPP in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The influence of intracellular mTHPC concentration upon photobleaching dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Fluence-rate effects upon m-THPC photobleaching in a formalin-fixed cell system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Intracellular photobleaching of 5,10,15,20-tetrakis(m-hydroxyphenyl) chlorin (Foscan) exhibits a complex dependence on oxygen level and fluence rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photobleaching of hypericin bound to human serum albumin, cultured adenocarcinoma cells and nude mice skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Binding of temoporfin to the lipoprotein fractions of human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The high photoactivity of m-THPC in photodynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Investigation of Foscan interactions with plasma proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Fluorescence imaging of Foscan and Foslip in the plasma membrane and in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Fluorescence anisotropy imaging reveals localization of meso-tetrahydroxyphenyl chlorin in the nuclear envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Human ABC transporter isoform B6 (ABCB6) localizes primarily in the Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Temporally and spatially heterogeneous distribution of mTHPC in a murine tumor observed by two-color confocal fluorescence imaging and spectroscopy in a whole-mount model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Ex vivo quantification of mTHPC concentration in tissue: influence of chemical extraction on the optical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The biology of photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Tissue photosensitizer detection by low-power remittance fluorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Indirect detection of photosensitizer ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

State of the art in the delivery of photosensitizers for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Does the in-vitro efficiency of meso-tetrahydroxy-phenyl-chlorin depend on pre-treatment of sensitizer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Nanoparticles in photodynamic therapy: an emerging paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Nanodrug applications in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Enhanced photodynamic effects using fractionated laser light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The influence of photodynamic therapy on the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitized production of singlet oxygen: spatially-resolved optical studies in single cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Is nitric oxide important in photodynamic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Activation of poly(adenosine diphosphate-ribose) polymerase in mouse tumors treated by photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitization of isolated rat liver mitochondria by tetra(m-hydroxyphenyl)chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Decreased efficiency of trypsinization of cells following photodynamic therapy: evaluation of a role for tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Expression of the collagen-related heat shock protein HSP47 in fibroblasts treated with hyperthermia or photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo expression of the collagen-related heat shock protein HSP47, following hyperthermia or photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Apoptosis, autophagy and cell cycle arrest following photodamage to mitochondrial interior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Post-exposure processes in Temoporfin-photosensitized cells in vitro: reliance on energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Correlation of death modes of photosensitized cells with intracellular ATP concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

PDT effects of m-THPC and ALA, phototoxicity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effects of BAPTA-AM, Forskolin, DSF and Z.VAD.fmk on PDT-induced apoptosis and m-THPC phototoxicity on B16 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Role of p53 and ATM in photodynamic therapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cooperative effects of photodynamic treatment of cells in microcolonies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Basic research on the biology of meta-tetra(hydroxyphenyl) chlorin for photodynamic therapy in gynaecology: Somatic genotoxicity assayed withDrosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A comet assay of DNA damage and repair in K562 cells after photodynamic therapy using haematoporphyrin derivative, methylene blue and meso-tetrahydroxyphenylchlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Use of alkaline Comet assay to assess DNA repair after m-THPC-PDT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy and anti-tumour immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Immunological Aspects of Photodynamic Therapy of Liver Tumors in a Rat Model for Colorectal Cancer¶

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photocytotoxic and DNA damaging effect of temoporfin (mTHPC) and merocyanine 540 (MC540) on nasopharyngeal carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy as a tool for suppressing the haematogenous dissemination of tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Induction of early apoptosis in human nasopharyngeal carcinoma cells by mTHPC-mediated photocytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The characterisation of three substituted zinc phthalocyanines of differing charge for use in photodynamic therapy. A comparative study of their aggregation and photosensitising ability in relation to mTHPC and polyhaematoporphyrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Specific fluorescent tracers. Imaging and applications for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Investigation of cross-resistance to a range of photosensitizers, hyperthermia and UV light in two radiation-induced fibrosarcoma cell strains resistant to photodynamic therapy in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic effect of novel chlorin e6 derivatives on a single nerve cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an 'early' squamous cell carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Foscan uptake and tissue distribution in relation to photodynamic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Fine-needle interstitial photodynamic therapy of the lung parenchyma: photosensitizer distribution and morphologic effects of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial laser photocoagulation and interstitial photodynamic therapy of normal lung parenchyma in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Characterization of a murine model for the rapid assessment of acute photodynamic response in tumour and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy and endoscopic mucosal resection as minimally invasive approaches for the treatment of early esophageal tumors: Pre-clinical and clinical experience in Lausanne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Assessment of a sheep animal model to optimise photodynamic therapy in the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy induced esophageal stricture--an animal model: from mouse to pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Experimental evaluation of possible side effects of intra‐operative photodynamic therapy on rabbit blood vessels and nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Performance of a contact textile-based light diffuser for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitising drugs - their potential in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The present and future role of photodynamic therapy in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitizers in clinical PDT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Oncologic photodynamic therapy photosensitizers: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

PD/PDT for gynecological disease: A clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Treating basal cell carcinoma: has photodynamic therapy come of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy in oesophageal carcinoma: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial photodynamic therapy for prostate cancer: a developing modality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for pancreatic carcinoma: experimental and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for urological malignancies: past to current approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Skin protection for photosensitized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Quality of life and oral function following radiotherapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Use of photodynamic therapy for the treatment of squamous cell carcinoma of the soft palate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Prospects for future studies in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The application and challenges of clinical PD-PDT in the head and neck region: a short review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Clinical photodynamic therapy of head and neck cancers-A review of applications and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using mTHPC for malignant disease in the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

mTHPC-mediated photodynamic diagnosis of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial photodynamic therapy for a symptom-targeted treatment of complex vascular malformations in the head and neck region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Advances in photodynamic therapy for the treatment of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Interstitial photodynamic laser therapy in interventional oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The surgical palliation of advanced head and neck cancer using photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cystic hygroma treated with ultrasound guided interstitial photodynamic therapy: case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Endoluminal carotid stenting prior to photodynamic therapy to pericarotid malignant disease: technical advance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Analysis of cost effectiveness of photodynamic therapy with Foscan (Foscan-PDT) in comparison with palliative chemotherapy in patients with advanced head-neck tumors in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A clinical review of PDT for cutaneous malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Light dosimetry for photodynamic therapy in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy and photodiagnosis for Barrett's oesophagus and early oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for dysplastic Barrett's oesophagus and early cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The role of photodynamic therapy in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Emerging technologies for the thorax: indications, management and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy in the management of malignant pleural mesothelioma: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of the intact breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

[Experimental investigations and clinical use of photodynamic therapy (PDT) in the Rudolf Foundation Hospital].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for recurrent gynecologic malignancy: a report on 4 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Extensive vulval intraepithelial neoplasia treated with a new regime of systemic photodynamic therapy using meta-tetrahydroxychlorin (Foscan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for intraepithelial neoplasia of the lower genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Brain photodiagnosis (PD), fluorescence guided resection (FGR) and photodynamic therapy (PDT): past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic applications in brain tumors: a comprehensive review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for cancer of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

21 January 2018

Prostate PDT dosimetry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo photosensitizer tomography inside the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Advances in photodynamic therapy for the treatment of hilar biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cholangiocarcinoma: an emerging indication for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The practicalities of photodynamic therapy in acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy for periodontal diseases: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Antifungal photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic treatment as a novel approach in the therapy of arthritic joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy of age-related macular degeneration: History and principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Structure-activity relationship of porphines for photoinactivation of bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Experimental survey of non-clonogenic viability assays for adherent cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy in normal pig stomach: protective effect of octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Water disinfection using photosensitizers immobilized on chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Endobronchial photodynamic therapy: comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

mTHPC Polymer Conjugates: The In Vivo Photodynamic Activity of Four Candidate Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

PEG-m-THPC-mediated photodynamic effects on normal rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Biodistribution of meta-tetra(hydroxyphenyl)chlorin incorporated into surface-modified nanocapsules in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A comparative study of the cellular uptake, localization and phototoxicity of meta-tetra(hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Early apoptotic responses in transgenic mouse mammary carcinoma for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodegradation and phototransformation of 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC) in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cancer chemotherapy with lipid-based nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Liposomal delivery of photosensitising agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Nanotechnology and the transdermal route: A state of the art review and critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Inclusion of a photosensitizer in liposomes formed by DMPC/gemini surfactant: correlation between physicochemical and biological features of the complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Temoporfin-loaded liposomes: physicochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitizing properties of chlorins in solution and in membrane-mimicking systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Unusual photoinduced response of mTHPC liposomal formulation (Foslip).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

m-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Cationic liposomes, loaded with m-THPC, in photodynamic therapy for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Gemini surfactant based carriers in gene and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Temoporfin-loaded liposomal gels: viscoelastic properties and in vitro skin penetration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Stability evaluation of temoporfin-loaded liposomal gels for topical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photosensitizer loaded HSA nanoparticles II: in vitro investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Quantum dots as photosensitizers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d,l-lactide) diblock copolymer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Development of pH sensitive 2-(diisopropylamino)ethyl methacrylate based nanoparticles for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Multilayer coating of gold nanoparticles with drug-polymer coadsorbates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Flow cytometry as a new approach to investigate drug transfer between lipid particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Comparative in vitro study on the characteristics of different photosensitizers employed in PDT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Spray-dried microparticles containing polymeric micelles encapsulating hematoporphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Two-photon excitation studies of m-THPC photosensitizer and photodynamic activity in an epithelial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Two-photon absorption and the design of two-photon dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Lasers and light sources for PDT: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

In vivo quantification of chromophore concentration using fluorescence differential path length spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The role of photodynamic therapy (PDT) physics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Development and applications of photo-triggered theranostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

The future of photodynamic therapy in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy: novel third-generation photosensitizers one step closer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

PDT in clinics: indications, results, and markets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Art and science of photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Clinical PD/PDT in North America: An historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Photodynamic therapy: a clinical reality in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Efficiency of liposomes in the delivery of a photosensitizer controlled by the stereochemistry of a gemini surfactant component

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Overexpression of Bcl-2 enhances sensitivity of L929 cells to a lipophilic cationic photosensitiser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X

Protective Effect of β-Carotene against Lethal Photosensitization by Hæmatoporphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00986.X